SEVIKAR HCT 40/5/25 olmesartan medoxomil 40 mg amlodipine (as besilate) 5 mg and hydrochlorothiazide 25 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

sevikar hct 40/5/25 olmesartan medoxomil 40 mg amlodipine (as besilate) 5 mg and hydrochlorothiazide 25 mg tablet blister pack

organon pharma pty ltd - olmesartan medoxomil, quantity: 40 mg; hydrochlorothiazide, quantity: 25 mg; amlodipine besilate, quantity: 6.944 mg (equivalent: amlodipine, qty mg) - tablet - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; croscarmellose sodium; magnesium stearate; colloidal anhydrous silica; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - sevikar hct is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination (see dosage and administration). this fixed dose combination is not indicated for initial therapy

SEVIKAR HCT 40/10/25 olmesartan medoxomil 40 mg amlodipine (as besilate) 10 mg and hydrochlorothiazide 25 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

sevikar hct 40/10/25 olmesartan medoxomil 40 mg amlodipine (as besilate) 10 mg and hydrochlorothiazide 25 mg tablet blister pack

organon pharma pty ltd - olmesartan medoxomil, quantity: 40 mg; amlodipine besilate, quantity: 13.888 mg/mg (equivalent: amlodipine, qty mg); hydrochlorothiazide, quantity: 25 mg - tablet - excipient ingredients: magnesium stearate; microcrystalline cellulose; croscarmellose sodium; pregelatinised maize starch; colloidal anhydrous silica; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - sevikar hct is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination (see dosage and administration). this fixed dose combination is not indicated for initial therapy

SEVIKAR HCT 20/5/12.5 olmesartan medoxomil 20 mg amlodipine (as besilate) 5 mg and hydrochlorothiazide 12.5mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

sevikar hct 20/5/12.5 olmesartan medoxomil 20 mg amlodipine (as besilate) 5 mg and hydrochlorothiazide 12.5mg tablet blister pack

organon pharma pty ltd - olmesartan medoxomil, quantity: 20 mg; amlodipine besilate, quantity: 6.944 mg (equivalent: amlodipine, qty mg); hydrochlorothiazide, quantity: 12.5 mg - tablet - excipient ingredients: microcrystalline cellulose; magnesium stearate; pregelatinised maize starch; croscarmellose sodium; colloidal anhydrous silica; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - sevikar hct is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination (see dosage and administration). this fixed dose combination is not indicated for initial therapy

AMLODIPINE/VALSARTAN NOVARTIS10/320 amlodipine 10 mg/valsartan 320 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

amlodipine/valsartan novartis10/320 amlodipine 10 mg/valsartan 320 mg film-coated tablet blister pack

novartis pharmaceuticals australia pty ltd - amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg); valsartan, quantity: 320 mg - tablet, film coated - excipient ingredients: crospovidone; colloidal anhydrous silica; sodium starch glycollate; microcrystalline cellulose; magnesium stearate; iron oxide yellow; titanium dioxide; hypromellose; purified talc; macrogol 4000 - amlodipine/valsartan novartis is indicated for the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

AMLODIPINE/VALSARTAN NOVARTIS 5/320 amlodipine 5 mg/valsartan 320 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

amlodipine/valsartan novartis 5/320 amlodipine 5 mg/valsartan 320 mg film-coated tablet blister pack

novartis pharmaceuticals australia pty ltd - amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg); valsartan, quantity: 320 mg - tablet, film coated - excipient ingredients: crospovidone; sodium starch glycollate; iron oxide yellow; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; hypromellose; purified talc; iron oxide red; macrogol 4000 - amlodipine/valsartan novartis is indicated for the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

AMLODIPINE/VALSARTAN NOVARTIS 10/160 amlodipine 10 mg/valsartan 160 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

amlodipine/valsartan novartis 10/160 amlodipine 10 mg/valsartan 160 mg film-coated tablet blister pack

novartis pharmaceuticals australia pty ltd - amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg); valsartan, quantity: 160 mg - tablet, film coated - excipient ingredients: magnesium stearate; microcrystalline cellulose; colloidal anhydrous silica; crospovidone; titanium dioxide; hypromellose; purified talc; macrogol 4000; iron oxide red; iron oxide yellow - amlodipine/valsartan novartis is indicated for the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Amlodipine/Valsartan Teva 5mg/160mg Film-coated Tablets Malta - English - Medicines Authority

amlodipine/valsartan teva 5mg/160mg film-coated tablets

teva b.v. swensweg 5, 2031 ga haarlem, netherlands - amlodipine besylate, valsartan - film-coated tablet - amlodipine besylate 5 mg valsartan 160 mg - agents acting on the renin-angiotensin system

Amlodipine/Valsartan Teva 10mg/160mg Film-coated Tablets Malta - English - Medicines Authority

amlodipine/valsartan teva 10mg/160mg film-coated tablets

teva b.v. swensweg 5, 2031 ga haarlem, netherlands - amlodipine besylate, valsartan - film-coated tablet - amlodipine besylate 10 mg valsartan 160 mg - agents acting on the renin-angiotensin system

Amlodipine/Valsartan Teva 5mg/80mg fILM-COATED tABLETS Malta - English - Medicines Authority

amlodipine/valsartan teva 5mg/80mg film-coated tablets

teva b.v. swensweg 5, 2031 ga haarlem, netherlands - amlodipine besylate, valsartan - film-coated tablet - amlodipine besylate 5 mg valsartan 80 mg - agents acting on the renin-angiotensin system

OLMEKAR HCT 20/5/12.5 olmesartan medoxomil/amlodipine (as besilate) and hydrochlorothiazide 20 mg/5 mg/12.5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

olmekar hct 20/5/12.5 olmesartan medoxomil/amlodipine (as besilate) and hydrochlorothiazide 20 mg/5 mg/12.5 mg tablet blister pack

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 6.935 mg (equivalent: amlodipine, qty 5 mg); hydrochlorothiazide, quantity: 12.5 mg; olmesartan medoxomil, quantity: 20 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; magnesium stearate; croscarmellose sodium; pregelatinised maize starch; microcrystalline cellulose; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - it is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination.this fixed dose combination is not indicated for initial therapy.